Life Sciences Investor Forum today announced that the presentations from the June 25th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.

This virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company’s “virtual trade booth”.

REGISTER OR LOGIN AT:  https://tinyurl.com/062520LSIFPostPR

June 25th Presenting Companies:

Company Ticker
RedHill Biopharma Ltd. Nasdaq: RDHL
Orexo AB OTCQX: ORXOY | Nasdaq STO: ORX
Citius Pharmaceuticals, Inc. Nasdaq: CTXR
SWK Holdings, Inc Nasdaq: SWKH
Starpharma Holdings Ltd. OTCQX: SPHRY | ASX: SPL
CNS Pharmaceuticals, Inc. Nasdaq: CNSP
Sixth Wave Innovations Inc. OTCQB: ATURF | CSE: SIXW | FSE: AHUH
Moleculin Biotech, Inc. Nasdaq: MBRX
Novan, Inc. Nasdaq: NOVN

To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com.

About Life Sciences Investor ForumLife Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.

A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

CONTACT
Life Sciences Investor Forum
John M. Viglotti
SVP Corporate Services, Investor Access
(212) 220-2221
johnv@lifesciencesinvestorforum.com 
Moleculin Biotech (NASDAQ:MBRX)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024 Click aqui para mais gráficos Moleculin Biotech.
Moleculin Biotech (NASDAQ:MBRX)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024 Click aqui para mais gráficos Moleculin Biotech.